ProCE Banner Activity

EPIC-NSW: Lessons From a Real-World PrEP Implementation Study

Clinical Thought
Australian study shows overwhelming demand and uptake of PrEP and highlights the power of partnering among government, clinical, and academic institutions.

Released: March 18, 2022

Expiration: March 17, 2023

No longer available for credit.

Share

Supporters

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare